Wednesday, June 10, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Biotherapeutics, Inc.”

156 pharma patents match "Biotherapeutics, Inc." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 156
Index total 30,257
Page 3 / 7

Quick answer

This filtered view shows 156 pharmaceutical patents matching "Biotherapeutics, Inc." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

156 results for “Biotherapeutics, Inc.” · 30,257 patents in full index Clear search

  1. US 11753474

    Anti-Dectin-2 antibodies

    Bolt Biotherapeutics, Inc. · Granted Sep 12, 2023 · Expires Sep 7, 2043

    granted
  2. US 11730740

    Laureth-4 containing topical formulations

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted
  3. US 11713446

    Processes for generating TIL products enriched for tumor antigen-specific T-cells

    Iovance Biotherapeutics, Inc. · Granted Aug 1, 2023 · Expires Jul 27, 2043

    granted
  4. US 11707454

    Topical roflumilast formulation having antifungal properties

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted Jul 25, 2023 · Expires Jul 20, 2043

    granted
  5. US 11667890

    Engineered artificial antigen presenting cells for tumor infiltrating lymphocyte expansion

    Iovance Biotherapeutics, Inc. · Granted Jun 6, 2023 · Expires Jun 1, 2043

    granted
  6. US 11654199

    Thienoazepine immunoconjugates, and uses thereof

    Bolt Biotherapeutics, Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  7. US 11655455

    Enhanced systems for cell-mediated oncolytic viral therapy

    Calidi Biotherapeutics, Inc. · Granted May 23, 2023 · Expires May 18, 2043

    granted
  8. US 11628177

    Compositions and methods for deep dermal drug delivery

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted
  9. US 11631483

    Systems and methods for coordinating manufacturing of cells for patient-specific immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Apr 18, 2023 · Expires Apr 13, 2043

    granted
  10. US 11607450

    Smallpox vaccine for cancer treatment

    Calidi Biotherapeutics, Inc. · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted
  11. US 11547761

    Antibody adjuvant conjugates

    Bolt Biotherapeutics, Inc. · Granted Jan 10, 2023 · Expires Jan 5, 2043

    granted
  12. US 11541070

    Administration of an anti-activin-A compound to a subject

    Atara Biotherapeutics, Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  13. US 11541077

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jan 3, 2023 · Expires Dec 29, 2042

    granted
  14. US 11534493

    Pharmaceutical compositions of roflumilast in aqueous blends of water-miscible, pharmaceutically acceptable solvents

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted Dec 27, 2022 · Expires Dec 22, 2042

    granted
  15. US 11529372

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Dec 20, 2022 · Expires Dec 15, 2042

    granted
  16. US 11517592

    Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Dec 6, 2022 · Expires Dec 1, 2042

    granted
  17. US 11505782

    Cell-based vehicles for potentiation of viral therapy

    Calidi Biotherapeutics, Inc. · Granted Nov 22, 2022 · Expires Nov 17, 2042

    granted
  18. US 11433097

    Methods of using tumor infiltrating lymphocytes in double-refractory melanoma

    Iovance Biotherapeutics, Inc. · Granted Sep 6, 2022 · Expires Sep 1, 2042

    granted
  19. US 11401507

    Remnant tumor infiltrating lymphocytes and methods of preparing and using the same

    Iovance Biotherapeutics, Inc. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  20. US 11400164

    Immunoconjugates targeting HER2

    Bolt Biotherapeutics, Inc. · Granted Aug 2, 2022 · Expires Jul 28, 2042

    granted
  21. US 11384337

    Closed process for expansion and gene editing of tumor infiltrating lymphocytes and uses of same in immunotherapy

    Iovance Biotherapeutics, Inc. · Granted Jul 12, 2022 · Expires Jul 7, 2042

    granted
  22. US 11369637

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Jun 28, 2022 · Expires Jun 23, 2042

    granted
  23. US 11364266

    Restimulation of cryopreserved tumor infiltrating lymphocytes

    Iovance Biotherapeutics, Inc. · Granted Jun 21, 2022 · Expires Jun 16, 2042

    granted
  24. US 11357841

    Expansion of tumor infiltrating lymphocytes with potassium channel agonists and therapeutic uses thereof

    Iovance Biotherapeutics, Inc. · Granted Jun 14, 2022 · Expires Jun 9, 2042

    granted